Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $321.38M | $280.05M | $303.44M | $311.31M | $294.34M | $254.52M | $290.20M | $285.47M |
| Cost of revenue | $143.41M | $132.98M | $137.52M | $133.75M | $127.72M | $119.09M | $125.84M | $127.44M |
| Gross profit | $177.96M | $147.07M | $165.92M | $177.56M | $166.62M | $135.43M | $164.37M | $158.02M |
| Gross margin | 55.4% | 52.5% | 54.7% | 57.0% | 56.6% | 53.2% | 56.6% | 55.4% |
| Selling, general and administrative | $68.16M | $68.21M | $57.51M | $63.29M | $68.89M | $63.06M | $61.84M | $62.01M |
| Operating expenses | $71.17M | $71.24M | −$4.41M | $66.38M | $112.19M | $109.33M | $77.22M | $77.52M |
| Operating income | $106.79M | $75.83M | $170.33M | $111.18M | $54.43M | $26.10M | $87.15M | $80.51M |
| Operating margin | 33.2% | 27.1% | 56.1% | 35.7% | 18.5% | 10.3% | 30.0% | 28.2% |
| EBITDA | $140.19M | $106.64M | $137.91M | $139.54M | $123.45M | $97.85M | $127.46M | $123.57M |
| Interest income | $0 | $0 | −$155.72M | — | $0 | $0 | −$164.69M | — |
| Interest expense | −$34.41M | −$34.75M | $120.67M | −$39.15M | −$40.65M | −$40.88M | $123.73M | −$41.57M |
| Income before taxes | $78.05M | $42.61M | $70.50M | $72.94M | $18.90M | −$14.82M | $44.96M | $42.75M |
| Income taxes | $24.41M | $16.02M | $35.65M | $24.54M | $10.94M | −$1.56M | $32.64M | $25.76M |
| Net income | $53.64M | $26.59M | $34.85M | $48.40M | $7.96M | −$13.26M | $12.32M | $17.00M |
| Net margin | 16.7% | 9.5% | 11.5% | 15.5% | 2.7% | -5.2% | 4.2% | 6.0% |
| EPS, basic | $0.19 | $0.09 | $0.12 | $0.17 | $0.03 | −$0.05 | $0.04 | $0.06 |
| EPS, diluted | $0.19 | $0.09 | $0.12 | $0.17 | $0.03 | −$0.05 | $0.04 | $0.06 |
| Diluted shares | 288.15M | 287.62M | 289.63M | 286.75M | 285.76M | 283.56M | 285.46M | 285.56M |
Figures describe Sotera Health shares, not any token. As of Aug 6, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.